ISSN 2415-1297 (Online)   ISSN 2415-1300 (Print)
 
             
 
Volume : 30 Issue : 1 Year : 2023
 
Anticardiolipin Antibodies in Recurrent Fetal Loss [Med J Islamic World Acad Sci]
Med J Islamic World Acad Sci. 1988; 1(2): 143-146

Anticardiolipin Antibodies in Recurrent Fetal Loss

A. Metin Gülmezoglu1, S. Ergüven2, Ü. Büyükkagnıcı1, E. Gülmezoglu2, Z. Durmus1
1From Dr. Zekai Tahir Burak Women's Hospital, Ankara, Turkiye.
2From Hacettepe University, Department of Microbiology, Ankara, Turkiye.

Antiphospholipid antibodies can be detected both in some autoimmune disorders and in women with habitual abortion without evidence of a clinical autoimmune disease. Anticardiolipin antibodies and lupus anticoagulant factor are the two antiphospolipid antibodies which seem to have a role in habitual and spontaneous abortions, fetal growth retardation and intrauterine fetal deaths. The cause of the fetoplacental pathology remains unknown but it is likely that the thrombotic tendency observed in these patients also involves the decidual and placental blood vessels. A possible explanation for this thrombotic tendency has been the inhibition of vascular prostacyclin synthesis with resultant thromboxane dominance. We studied the incidence of anticardiolipin antibodies and lupus anticoagulant factor in habitual and spontaneous abortions and intrauterine fetal deaths in this report. An increased incidence of anticardiolipin antibodies was found in women with unexplained recurrent fetal loss.

Keywords: Anticardiolipin Antibodies, Lupus Anticoagulant Factor, Habitual Abortion.


A. Metin Gülmezoglu, S. Ergüven, Ü. Büyükkagnıcı, E. Gülmezoglu, Z. Durmus. Anticardiolipin Antibodies in Recurrent Fetal Loss. Med J Islamic World Acad Sci. 1988; 1(2): 143-146

Corresponding Author: A. Metin Gülmezoglu, Türkiye


TOOLS
Full Text PDF
Print
Download citation
RIS
EndNote
BibTex
Medlars
Procite
Reference Manager
Share with email
Share
Send email to author

Similar articles
PubMed
Google Scholar




   
Copyright © 2024 medicaljournal-ias.org. All Rights Reserved.